Ton Logtenberg

Ton Logtenberg is a founder, President and Chief Executive Officer of Merus N.V., a Nasdaq-listed Immuno-oncology company headquartered in Utrecht, The Netherlands. Ton also co-founded Crucell N.V., serving as its Executive Vice President and Chief Scientific Officer from 2000 until 2003. In 2016, he was appointed professor of Biomedical Entrepreneurship at Utrecht University and serves as a member of the board of directors of the Jenner Foundation, a member of the supervisory board of Utrecht Science Park and a member of the supervisory board of the Foundation Hubrecht Organoid Technology. Prof. Logtenberg holds a Ph.D. in medical biology from Utrecht University.

May 27, 2020 Studying the development of ovarian cancer wi... Researchers from the group of Hans Clevers at the Hubrecht Institute have modeled the development and progression of hig... read more
May 26, 2020 HUB Patient-Derived Organoids added to CrownB... San Diego, Calif – May 19, 2020 — Crown Bioscience today announced the expansion of their unique organoid platform w... read more
May 13, 2020 Hormone-producing cells in the human gut are difficult to study, as they are very rare and unique to different species o... read more